312 related articles for article (PubMed ID: 32912206)
1. Human germline editing in the era of CRISPR-Cas: risk and uncertainty, inter-generational responsibility, therapeutic legitimacy.
Schleidgen S; Dederer HG; Sgodda S; Cravcisin S; Lüneburg L; Cantz T; Heinemann T
BMC Med Ethics; 2020 Sep; 21(1):87. PubMed ID: 32912206
[TBL] [Abstract][Full Text] [Related]
2. The CRISPR babies controversy: Responsibility and regulation in the spotlight.
Meyer M
EMBO Rep; 2020 Jul; 21(7):e50307. PubMed ID: 32468716
[TBL] [Abstract][Full Text] [Related]
3. Genome engineering through CRISPR/Cas9 technology in the human germline and pluripotent stem cells.
Vassena R; Heindryckx B; Peco R; Pennings G; Raya A; Sermon K; Veiga A
Hum Reprod Update; 2016 Jun; 22(4):411-9. PubMed ID: 26932460
[TBL] [Abstract][Full Text] [Related]
4. Embryonic Regulation and Research: What Is the Status of Human Germline Genome Editing in Australia?
Burbery R
J Law Med; 2020 Apr; 27(3):718-740. PubMed ID: 32406632
[TBL] [Abstract][Full Text] [Related]
5. The Promise of CRISPR for Human Germline Editing and the Perils of "Playing God".
Locke LG
CRISPR J; 2020 Feb; 3(1):27-31. PubMed ID: 32091254
[TBL] [Abstract][Full Text] [Related]
6. Ordo-Responsibility for Germline Gene Editing.
Ranisch R; Rudolph T; Cremer HJ; Knoepffler N
CRISPR J; 2020 Feb; 3(1):37-43. PubMed ID: 32091257
[TBL] [Abstract][Full Text] [Related]
7. [CRISPR/Cas-based genome editing in Aspergillus niger].
Zheng X; Zheng P; Sun J
Sheng Wu Gong Cheng Xue Bao; 2021 Mar; 37(3):980-990. PubMed ID: 33783162
[TBL] [Abstract][Full Text] [Related]
8. Legal issues regarding gene editing at the beginning of life: an EU perspective.
De Miguel Beriain I
Regen Med; 2017 Sep; 12(6):669-679. PubMed ID: 28976851
[TBL] [Abstract][Full Text] [Related]
9. A society-wide conversation is needed about germline genome editing using CRISPR.
Birney E
Nat Med; 2024 Jan; 30(1):30-32. PubMed ID: 38177854
[No Abstract] [Full Text] [Related]
10. [CRISPR/Cas: technique to repair DNA errors: is a clinical breakthrough near?].
van de Vrugt HJ; Cornel MC; Wolthuis RMF
Ned Tijdschr Geneeskd; 2018 Jun; 162():. PubMed ID: 30040285
[TBL] [Abstract][Full Text] [Related]
11. [Crispr-Cas9 Gene Editing Revolution and the Its Ethical and Legal Challenges].
Bellver Capella V
Cuad Bioet; 2016; 27(90):223-39. PubMed ID: 27637196
[TBL] [Abstract][Full Text] [Related]
12. Upstream Ethical Mapping of Germline Genome Editing.
Halpern J; Paolo D
Am J Bioeth; 2020 Aug; 20(8):1-4. PubMed ID: 32804067
[No Abstract] [Full Text] [Related]
13. Comparative analysis of mouse and human preimplantation development following POU5F1 CRISPR/Cas9 targeting reveals interspecies differences.
Stamatiadis P; Boel A; Cosemans G; Popovic M; Bekaert B; Guggilla R; Tang M; De Sutter P; Van Nieuwerburgh F; Menten B; Stoop D; Chuva de Sousa Lopes SM; Coucke P; Heindryckx B
Hum Reprod; 2021 Apr; 36(5):1242-1252. PubMed ID: 33609360
[TBL] [Abstract][Full Text] [Related]
14. FDA Regulation of Clinical Applications of CRISPR-CAS Gene-Editing Technology.
Grant EV
Food Drug Law J; 2016; 71(4):608-33. PubMed ID: 29140647
[TBL] [Abstract][Full Text] [Related]
15. Use of CRISPR/Cas Genome Editing Technology for Targeted Mutagenesis in Rice.
Xu R; Wei P; Yang J
Methods Mol Biol; 2017; 1498():33-40. PubMed ID: 27709567
[TBL] [Abstract][Full Text] [Related]
16. CRISPR and Gene Editing: A Game-changer in Drug Development.
Verma A; Sharma T; Awasthi A
Curr Pharm Des; 2024; 30(15):1133-1135. PubMed ID: 38584552
[TBL] [Abstract][Full Text] [Related]
17. Ethical Considerations in Therapeutic Clinical Trials Involving Novel Human Germline-Editing Technology.
Brokowski C; Adli M
CRISPR J; 2020 Feb; 3(1):18-26. PubMed ID: 32091258
[TBL] [Abstract][Full Text] [Related]
18. [Genome editing in plants directed by CRISPR/Cas ribonucleoprotein complexes].
Li X; Shi W; Geng LZ; Xu JP
Yi Chuan; 2020 Jun; 42(6):556-564. PubMed ID: 32694114
[TBL] [Abstract][Full Text] [Related]
19. CRISPR-Cas tools to study gene function in cytokinesis.
Husser MC; Skaik N; Martin VJJ; Piekny A
J Cell Sci; 2021 Apr; 134(8):. PubMed ID: 33912919
[TBL] [Abstract][Full Text] [Related]
20. Human Genome Editing and Ethical Considerations.
Krishan K; Kanchan T; Singh B
Sci Eng Ethics; 2016 Apr; 22(2):597-9. PubMed ID: 26154417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
